Sarah Jane Tribble
From this contributor
U.S. drug agency moves to guard against abuse of ‘orphan drug’ program
The Food and Drug Administration is changing the way it approves medicines known as 'orphan drugs' after revelations that drugmakers may be abusing a law intended to help patients with rare diseases.
U.S. drug agency moves to guard against abuse of ‘orphan drug’ program
Pharma teams up with rare-disease advocacy groups on Capitol Hill
Critics say vulnerable patients are being manipulated and the goals promoted are skewed by the pharma benefactors who want faster government approval for new products.
Pharma teams up with rare-disease advocacy groups on Capitol Hill
U.S. government plans to probe orphan drug program
Acting on a request from three influential U.S. senators, the government’s accountability arm confirmed that it will investigate potential abuses of the Orphan Drug Act.
U.S. government plans to probe orphan drug program
Senators call for investigation into possible abuses of Orphan Drug Act
Building on weeks of mounting pressure to address high prescription drug prices, three influential U.S. senators have asked the government’s accountability arm to probe the orphan drug program for potential misuse.
Senators call for investigation into possible abuses of Orphan Drug Act
Former head of FDA concerned about faster drug approvals
Robert Califf, the just-departed commissioner of the U.S. Food and Drug Administration, offers his take on the Trump administration's plans to speed up drug approvals and dramatically reduce regulations at the agency.
Former head of FDA concerned about faster drug approvals
Explore more from The Transmitter
The Transmitter’s favorite essays and columns of 2024
From sex differences in Alzheimer’s disease to enduring citation bias, experts weighed in on important scientific and practical issues in neuroscience.
The Transmitter’s favorite essays and columns of 2024
From sex differences in Alzheimer’s disease to enduring citation bias, experts weighed in on important scientific and practical issues in neuroscience.
Say what? The Transmitter’s top quotes of 2024
“We’ve cured mouse-heimer’s thousands of times...”—find out who said this to a Transmitter reporter, and read our other favorite quotes from the past year.
Say what? The Transmitter’s top quotes of 2024
“We’ve cured mouse-heimer’s thousands of times...”—find out who said this to a Transmitter reporter, and read our other favorite quotes from the past year.
The Transmitter’s favorite podcasts of 2024
Our picks include a deep dive into dopamine, the role of PKMzeta in memory, and studying the stomatogastric ganglion.
The Transmitter’s favorite podcasts of 2024
Our picks include a deep dive into dopamine, the role of PKMzeta in memory, and studying the stomatogastric ganglion.